MIRA INFORM REPORT

 

 

Report No. :

353537

Report Date :

10.12.2015

 

IDENTIFICATION DETAILS

 

Name :

BAYER TURK KIMYA SANAYII LTD. STI.

 

 

Registered Office :

Fatih Sultan Mehmet Mah Balkan Cad No:53 Umraniye Istanbul

 

 

Country :

Turkey

 

 

Date of Incorporation :

27.09.1965

 

 

Com. Reg. No.:

90406

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Manufacture and trade of pharmaceuticals and agricultural and human insecticides, trade of medical equipment. 

 

 

No. of Employee :

1.311

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Status :

Good 

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Turkey

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

TURKEY - ECONOMIC OVERVIEW

 

Turkey's largely free-market economy is increasingly driven by its industry and service sectors, although its traditional agriculture sector still accounts for about 25% of employment. An aggressive privatization program has reduced state involvement in basic industry, banking, transport, and communication, and an emerging cadre of middle-class entrepreneurs is adding dynamism to the economy and expanding production beyond the traditional textiles and clothing sectors. The automotive, construction, and electronics industries are rising in importance and have surpassed textiles within Turkey's export mix.

Oil began to flow through the Baku-Tbilisi-Ceyhan pipeline in May 2006, marking a major milestone that has brought up to 1 million barrels per day from the Caspian region to market. Several gas pipeline projects also are moving forward to help transport Caspian gas to Europe through Turkey, which over the long term will help address Turkey's dependence on imported oil and gas, which currently meets 97% of its energy needs.

After Turkey experienced a severe financial crisis in 2001, Ankara adopted financial and fiscal reforms as part of an IMF program. The reforms strengthened the country's economic fundamentals and ushered in an era of strong growth averaging more than 6% annually until 2008. Global economic conditions and tighter fiscal policy caused GDP to contract in 2009, but Turkey's well-regulated financial markets and banking system helped the country weather the global financial crisis, and GDP rebounded strongly to around 9% in 2010-11, as exports returned to normal levels following the recession. Two rating agencies upgraded Turkey's debt to investment grade in 2012 and 2013, and Turkey's public sector debt to GDP ratio fell to 33% in 2014. The stock value of Foreign Direct Investment reached nearly $195 billion at year-end 2014.

Despite these positive trends, GDP growth dropped to 4.4% in 2013 and 2.9% in 2014. Growth slowed considerably in the last quarter of 2014, largely due to lackluster consumer demand both domestically and in Europe, Turkey’s most important export market. High interest rates have also contributed to the slowdown in growth, as Turkey sharply increased interest rates in January 2014 in order to strengthen the country’s currency and reduce inflation. Turkey then cut rates in February 2015 in a bid to spur economic growth.

The Turkish economy retains significant weaknesses. Specifically, Turkey's relatively high current account deficit, domestic political uncertainty, and turmoil within Turkey's neighborhood leave the economy vulnerable to destabilizing shifts in investor confidence. Turkey also remains dependent on often volatile, short-term investment to finance its large current account deficit.

 

Source : CIA

 

COMPANY IDENTIFICATION

 

 

NAME

:

BAYER TURK KIMYA SANAYII LTD. STI.

HEAD OFFICE ADDRESS

:

Fatih Sultan Mehmet Mah Balkan Cad No:53 Umraniye Istanbul / Turkey

REMARKS ON HEAD OFFICE ADDRESS

:

The address was changed from "Cakmak Mah." to "Fatih Sultan Mehmet Mah." by the Municipality.

PHONE NUMBER

:

90-216-528 36 00

 

FAX NUMBER

:

90-216-527 87 00

 

WEB-ADDRESS

:

www.bayer.com.tr

 

 

LEGAL STATUS AND HISTORY

 

 

NOTES ON LEGAL STATUS AND HISTORY

:

The paid-in capital is declared by the subject. There is no certification for the paid-in capital..

TAX OFFICE

:

Buyuk Mukellefler

TAX NO

:

1530006166

REGISTRATION NUMBER

:

90406

REGISTERED OFFICE

:

Istanbul Chamber of Commerce

DATE ESTABLISHED

:

27.09.1965

LEGAL FORM

:

Limited Company

TYPE OF COMPANY

:

Private

REGISTERED CAPITAL

:

TL   101.185.125

PAID-IN CAPITAL

:

TL   101.185.125

HISTORY

:

Previous Registered Capital

:

TL 28.707.400

Changed On

:

17.02.2005 (Commercial Gazette Date /Number 24.02.2005/ 6247)

Previous Registered Capital

:

TL 71.358.600

Changed On

:

30.03.2007 (Commercial Gazette Date /Number 05.04.2007/ 6781)

Previous Registered Capital

:

TL 101.185.100

Changed On

:

31.12.2012 (Commercial Gazette Date /Number 07.01.2013/ 8230)

Merger

:

The subject took over and merged with “Bayer Kimya Uretim ve Hizmet Ltd Sti”, “Schering Alman Ilac ve Ecza Tic. Ltd. Sti.” and “Bayer Ilac Fabrikalari Ltd Sti."

Changed On

:

30.03.2007 (Commercial Gazette Date /Number 05.04.2007/ 6781)

Merger

:

The subject took over and merged with "Intendis Ilac Ticaret Ltd. Sti."

Changed On

:

31.12.2012 (Commercial Gazette Date /Number 07.01.2013/ 8230)

 

 

OWNERSHIP / MANAGEMENT

 

 

SHAREHOLDERS

:

Bayer AG

99,99 %

Bayer Pharma AG

0,01 %

 

 

REMARKS ON SHAREHOLDERS

:

We are informed that, the shareholders "Bayer AG" and "Bayer  Pharma AG" are companies located in Germany.

 

DIRECTORS

:

Bayer AG (Representative: Osman Demirel)

 

Sevgi Altinok

 

Hubert Konrad Braun

 

Baulem Saidi

 

Oya Canbas

 

Osman Demirel

 

Sven Schmidt

 

Carola Rena Dr. Portner

 

 

 

OPERATIONS

 

 

BUSINESS ACTIVITIES

:

Manufacture and trade of pharmaceuticals and agricultural and human insecticides, trade of medical equipment. 

 

The subject has declared that it has 53 liaison office in Turkey.

NACE CODE

:

DG.24.42

 

SECTOR

:

Chemicals

 

NUMBER OF EMPLOYEES

:

1.311

 

NET SALES

:

75.401 TL Thousand

(2000) 

128.104 TL Thousand

(2001) 

179.778 TL Thousand

(2002) 

237.742 TL Thousand

(2003) 

272.435 TL Thousand

(2004) 

377.761 TL Thousand

(2005) 

426.222 TL Thousand

(2006) 

559.287 TL Thousand

(2007) 

663.763 TL Thousand

(2008) 

696.775 TL Thousand

(2009) 

714.190 TL Thousand

(2010) 

788.982 TL Thousand

(2011) 

807.782 TL Thousand

(2012) 

813.498 TL Thousand

(2013) 

972.176 TL Thousand

(2014) 

 

 

IMPORT COUNTRIES

:

Germany

Belgium

Netherlands

China

 

MERCHANDISE IMPORTED

:

Chemicals

Raw materials

 

 

EXPORT VALUE

:

7.578.000 TL

(2000)

30.508.000 TL

(2001)

32.319.000 TL

(2002)

33.188.000 TL

(2003)

35.070.000 TL

(2004)

33.330.359 TL

(2005)

25.893.450 TL

(2006)

27.065.000 USD

(2007)

20.246.000 USD

(2008)

16.471.000 USD

(2009)

25.742 USD Thousand

(2010)

30.778 USD Thousand

(2011)

30.142 USD Thousand

(2012)

32.154 TL Thousand

(2013)

63.059 TL Thousand

(2014)

 

 

EXPORT COUNTRIES

:

Tajikistan

Spain

Greece

Germany

South Korea

France

Philippines

Mexico

Jordan

Indonesia

Colombia

Uruguay

Hong-Kong

Bangladesh

Kuwait

Middle East Countries

 

MERCHANDISE  EXPORTED

:

Drugs

Insecticides

Medical vitamins

Pharmaceuticals

 

HEAD OFFICE ADDRESS

:

Fatih Sultan Mehmet Mah Balkan Cad No:53 Umraniye Istanbul / Turkey

( owned )

 

 

BRANCHES

:

Factory  :  Gebze Kocaeli/Turkey (owned) (19.064 sqm)

 

Factory  :  Davutpasa Cad. Emintas Davutpasa San. Sit. No:103/518-519  Topkapi Istanbul/Turkey (owned)

 

Branch Office  :   Adana/Turkey (owned)

 

Branch Office  :   Ankara/Turkey (rented)

 

Branch Office  :   Izmir/Turkey (rented)

 

Branch Office  :   Samsun/Turkey (rented)

 

Branch Office  :   Bursa/Turkey (rented)

 

Branch Office  :   Malatya/Turkey

 

 

 

TREND OF BUSINESS

:

There was an upwards trend in  2014.

SIZE OF BUSINESS

:

Giant

 

 

FINANCE

 

 

MAIN DEALING BANKS

:

Akbank Asya Kurumsal Branch

Garanti Bankasi Kozyatagi Kurumsal Branch

HSBC Bank Genel Mudurluk Kurumsal Branch

 

PAYMENT BEHAVIOUR

:

Regular.

KEY FINANCIAL ELEMENTS

:

 

(2010) TL

(2011) TL

(2012) TL

(2013) TL

(2014) TL

Net Sales

714.190.389

788.982.374

807.781.910

813.498.113

972.176.171

Profit (Loss) Before Tax

5.326.789

54.445.261

45.727.256

50.609.841

60.489.450

Stockholders' Equity

176.071.579

218.934.664

252.606.344

267.787.922

276.336.361

Total Assets

450.390.352

518.219.616

572.777.231

647.147.107

827.959.336

 

 

COMMENT ON FINANCIAL POSITION

 

Capitalization

Fair As of 31.12.2014

Profitability

Low Net Profitability  in 2010

High Net Profitability  in 2011

Good Net Profitability  in 2012

Good Net Profitability  in 2013

Good Net Profitability  in 2014

 

General Financial Position

Fair

 

 

Incr. in producers’ price index

 

Average USD/TL

Average EUR/TL

Average GBP/ TL

 ( 2000 )

32,70 %

0,6251

0,5774

0,9480

 ( 2001 )

88,60 %

1,1991

1,0714

1,7300

 ( 2002 )

30,80 %

1,5168

1,3741

2,2001

 ( 2003 )

13,90 %

1,5302

1,7141

2,4982

 ( 2004 )

13,84 %

1,4266

1,7666

2,6001

 ( 2005 )

2,66 %

1,3499

1,6882

2,4623

 ( 2006 )

11,58 %

1,4309

1,7987

2,6377

 ( 2007 )

5,94 %

1,3075

1,7901

2,6133

 ( 2008 )

8,11 %

1,2858

1,8876

2,3708

 ( 2009 )

5,93 %

1,5460

2,1529

2,4094

 ( 2010 )

8,87 %

1,5128

2,0096

2,3410

 ( 2011 )

13,33 %

1,6797

2,3378

2,6863

 ( 2012 )

2,45 %

1,7995

2,3265

2,8593

 ( 2013 )

6,97 %

1,9179

2,5530

3,0178

 ( 2014 )

6,36 %

2,1891

2,8989

3,6060

 ( 01.01-30.11.2015)

6,06 %

2,7064

3,0117

4,1515

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.75

UK Pound

1

Rs.100.29

Euro

1

Rs.72.89

TRY

1

Rs. 22.95

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

ASH

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.